Objective To evaluate the effect of auto-peripheral blood stem cells transplantation (PBSCT) for acute leukemia (AL) without abnormal chromosome.
目的评价自体外周血造血干细胞移植（PBSCT）治疗无染色体异常的急性白血病（AL）的疗效。
The relapse or disease recurrence rates are similar regardless of whether the stem cells used for transplantation are from bone marrow, peripheral blood, or umbilical cord blood.
无论采用来自于外周血、骨髓或者脐血的干细胞进行移植，疾病的复发率都类似。
Peripheral blood stem cell transplantation involves using high-dose chemotherapy and transfusion of previously collected immature blood cells (stem cells) to replace diseased or damaged marrow.
周围血干细胞移植可能会用到大剂量化疗药物，要输入先前采集的未成熟血细胞(干细胞)来代替患病和受损的骨髓细胞。
Objective: to evaluate the clinical efficacy of mobilized autologous peripheral blood stem cells (PBSC) transplantation in old patients with lower limb chronic ischemia.
目的：评价外周血干细胞移植治疗老年人慢性下肢缺血的临床疗效。
CONCLUSION: Mesenchymal stem cells infusion enhanced hematopoietic reconstitution after peripheral blood stem cell transplantation.
结论：骨髓间质干细胞输注有促进外周血干细胞移植造血恢复的作用。
CONCLUSION: Mesenchymal stem cells infusion enhanced hematopoietic reconstitution after peripheral blood stem cell transplantation.
结论：骨髓间质干细胞输注有促进外周血干细胞移植造血恢复的作用。
应用推荐